Journal
ISCIENCE
Volume 23, Issue 5, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2020.101083
Keywords
-
Categories
Funding
- NIH [R35HL135747, R00NS077435, R01NS097850]
- New York Stem Cell Foundation
- USC Broad Innovation Award
- Hastings Foundation
- National Heart, Lung, and Blood Institute (NHLBI) [U01HL122642, 1U01HL122638]
Ask authors/readers for more resources
Expansion of pulmonary neuroendocrine cells (PNECs) is a pathological feature of many human lung diseases. Human PNECs are inherently difficult to study due to their rarity (<1% of total lung cells) and a lack of established protocols for their isolation. We used induced pluripotent stem cells (iPSCs) to generate induced PNECs (iPNECs), which express core PNEC markers, including ROBO receptors, and secrete major neuropeptides, recapitulating known functions of primary PNECs. Furthermore, we demonstrate that differentiation efficiency is increased in the presence of an air-liquid interface and inhibition of Notch signaling. Single-cell RNA sequencing (scRNA-seq) revealed a PNEC-associated gene expression profile that is concordant between iPNECs and human fetal PNECs. In addition, pseudotime analysis of scRNA-seq results suggests a basal cell origin of human iPNECs. In conclusion, our model has the potential to provide an unlimited source of human iPNECs to explore PNEC pathophysiology associated with several lung diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available